Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
1,983
Sort by:
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline guide also reviews of key players involved in therapeutic development for Uterine Leiomyoma (Uterine Fibroids) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
113 pages
Erectile Dysfunction - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Erectile Dysfunction (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Erectile Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
150 pages
Male Hypogonadism - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Male Hypogonadism (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Hypogonadism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
107 pages
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Ventilator Associated Pneumonia (VAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
176 pages
Amyloidosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Amyloidosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Amyloidosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
226 pages
Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Onychomycosis (Tinea Unguium) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Onychomycosis (Tinea Unguium) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
83 pages
Rheumatoid Arthritis - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Rheumatoid Arthritis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Rheumatoid Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
1156 pages
Smallpox - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Smallpox (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Smallpox and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
81 pages
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Acute Respiratory Distress Syndrome (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Acute Respiratory Distress Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
129 pages
Cholera - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cholera (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cholera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
63 pages
Typhoid Fever - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Typhoid Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
52 pages
Diabetic Macular Edema - Pipeline Review, H1 2020
US$ 2,000.00
... . The Diabetic Macular Edema (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Macular Edema and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
298 pages
Sarcopenia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Sarcopenia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sarcopenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
91 pages
Anthrax - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Anthrax (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
110 pages
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Hospital Acquired Pneumonia (HAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hospital Acquired Pneumonia (HAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
199 pages
Hypoglycemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypoglycemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypoglycemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
88 pages
Mumps - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Mumps (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Mumps and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
31 pages
Warts - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Warts (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Warts and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
111 pages
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2020
US$ 2,000.00
... . The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
99 pages
Chemotherapy Induced Neutropenia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chemotherapy Induced Neutropenia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
146 pages
Insulin Resistance - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Insulin Resistance (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Insulin Resistance and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
51 pages
Bacterial Vaginosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bacterial Vaginosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Vaginosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
72 pages
Degenerative Disc Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Degenerative Disc Disease (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Degenerative Disc Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
68 pages
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Peripheral Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
86 pages
Plague - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Plague (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Plague and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
70 pages
Botulism - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Botulism (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Botulism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
36 pages
Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Opioid-Induced Constipation (OIC) (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Opioid-Induced Constipation (OIC) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
53 pages
Lyme Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Lyme Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lyme Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
59 pages
Streptococcus pyogenes Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Streptococcus pyogenes Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Streptococcus pyogenes Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
35 pages
Community Acquired Pneumonia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Community Acquired Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Community Acquired Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
151 pages
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Elephantiasis (Lymphatic Filariasis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Elephantiasis (Lymphatic Filariasis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
31 pages
Phenylketonuria (PKU) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Phenylketonuria (PKU) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Phenylketonuria (PKU) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
82 pages
Cerebral Palsy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Cerebral Palsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cerebral Palsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
47 pages
Autism - Pipeline Review, H1 2020
US$ 2,000.00
... . The Autism (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Autism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
177 pages
Down Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Down Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Down Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
80 pages
Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Functional (Non Ulcer) Dyspepsia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
35 pages
Otitis Media - Pipeline Review, H1 2020
US$ 2,000.00
... . The Otitis Media (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Otitis Media and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
78 pages
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Reflux Esophagitis (Gastroesophageal Reflux Disease) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Reflux Esophagitis (Gastroesophageal Reflux Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
107 pages
Urinary Incontinence - Pipeline Review, H1 2020
US$ 2,000.00
... Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Urinary Incontinence and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
74 pages
Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Venous Leg Ulcers (Crural ulcer) (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Venous Leg Ulcers (Crural ulcer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
68 pages
Alopecia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
190 pages
Colitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
121 pages
Diarrhea - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Diarrhea (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
153 pages
Fatigue - Pipeline Review, H1 2020
US$ 2,000.00
... . The Fatigue (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Fatigue and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
39 pages
Tourette Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... . The Tourette Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Tourette Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
86 pages
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2020
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
197 pages
Alcohol Addiction - Pipeline Review, H1 2020
US$ 2,000.00
... . The Alcohol Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alcohol Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
183 pages
Ischemia Reperfusion Injury - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ischemia Reperfusion Injury (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Ischemia Reperfusion Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
177 pages
Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Systemic Sclerosis (Scleroderma) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Systemic Sclerosis (Scleroderma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
374 pages
